Skip to content
Medical Health Aged Care, Mental Health

Monash University Expert: World Mental Health Day, 10 October 2023

Monash University 2 mins read
Sourced from iStock

This year the theme for World Mental Health Day is ‘mental health is a universal right’. An expert in medical treatments for mental health conditions from Monash University is available for comment.

Professor Chris Langmead, Director of the Neuromedicines Discovery Centre, Monash Institute of Pharmaceutical Sciences
Contact: M: +61 (0)417 959083 / E: chris.langmead@monash.edu 

  • There have been no new medicines to treat mental health conditions for 50+ years - in order to make real change to the overall quality of life for patients, this must change.     

  • Limited resources/funding invested into research for the discovery and development of novel medicines to treat mental health conditions has hindered progress. 

  • Accessibility is key - when new medicines (including treatments such as psychedelic-assisted therapy) become an option, they must be rigorously assessed from an economic perspective to ensure they are not reserved to only a small number of patients who can afford them. 

The following quotes can be attributed to Professor Langmead:

“Mental health is a basic human right for everyone, yet one in eight people globally are living with a mental health condition. We need new drugs that are safe and more effective than current options, particularly for difficult to treat mental health conditions. But they also need to be affordable for everyone in need, not just small cohorts of the population.

“Since the 1970s there have been extraordinary breakthroughs in medical treatments for many diseases like cancer, diabetes, heart disease and dementia. Yet new medicines to treat mental health conditions have remained stagnant, due in part to limited resources and funding.

“Recently Australia’s Therapeutic Goods Administration (TGA) approved the use of MDMA and psilocybin for the treatment of post-traumatic stress disorder (PTSD) and treatment-resistant depression, respectively. This has opened up really exciting new opportunities for Australia, however there are still major issues to tackle in order for the TGA’s reclassification to benefit those most in need.


Contact details:

Kate Carthew

+61 438 674 814

kate.carthew@monash.edu

Media

More from this category

  • Medical Health Aged Care
  • 27/02/2024
  • 23:07
Monopar Therapeutics Inc.

Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial

WILMETTE, Ill., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced that the internationally recognized radiopharmaceutical physician, Professor Rodney Hicks, will be the lead investigator for Monopar’s MNPR-101-Zr Phase 1 dosimetry clinical trial in advanced cancer patients. Professor Hicks will enroll patients at the Melbourne Theranostic Innovation Centre (MTIC) and will use one of the world's most sensitive clinical total-body PET/CT (positron emission tomography–computed tomography) scanners, the Siemens Biograph Vision Quadra, to image the targeting ability of MNPR-101-Zr in cancer patients.“We are very excited…

  • Indigenous, Medical Health Aged Care
  • 27/02/2024
  • 14:26
Institute for Urban Indigenous Health

Reduction in Indigenous newborn removals by child protection services

Australian research published this month shows women who received care through an innovative Indigenous-led model of maternity care were three times less likely to have their Indigenous newborn removed by child protection services than women who received standard maternity care. The research lands at the same time as the Australian Government’s Closing the Gap 2023 Annual Report which shows the rate of over-representation of Indigenous children in out-of-home care in Australia continues to increase. Kristie Watego, Birthing in Our Community (BiOC) Service Development Manager, Institute for Urban Indigenous Health (IUIH), said the results show it is possible to significantly reduce…

  • Medical Health Aged Care
  • 27/02/2024
  • 09:31
Dementia Australia

Come walk or jog with us in Perth. We are in this together!

The 2024 Perth Memory Walk & Jog is nearly here with the event taking place on Sunday 17 March at Burswood Park, Burswood. Dementia Australia’s largest fundraising event hopes to attract thousands of people across Australia to help raise more than $2 million in support of people living with dementia. Funds raised at our upcoming event in Perth will help advance the work of Dementia Australia which delivers invaluable support, education and resources for people living with dementia, their families and carers. Memory Walk & Jog is about being part of the community and feeling supported. We are in this…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.